Trial intelligence / Profile preview

Acute Effects of Oxygen in PAH

NCT03683082Unknown

Sponsor
G. Papanikolaou General Hospital
Start
Jun 2018
Primary completion
Jun 2019
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised, single-blind trial of oxygen in pulmonary arterial hypertension (PAH) (2 arms), sponsored by G. Papanikolaou General Hospital. Primary endpoint: Exercise duration. Status: unknown.

02

Drugs

oxygen
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NCT03683082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03683082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call